Fintepla Unlikely to Cause Heart Valve Problems, PAH in Young Patients, Extension Study Finds
News
Children with Dravet syndrome receiving Fintepla (fenfluramine) to control their seizures are unlikely to develop cardiac valvulopathy — a disease in which at least one of the four heart ... Read more